Omalizumab for Injection - Global and China Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Pharma & Healthcare > Omalizumab for Injection - Global and China Top Players Market Share and Ranking 2025

Omalizumab for Injection - Global and China Top Players Market Share and Ranking 2025

Publication Date: 2025-08-19
Report Id: 2181863
Industry: Pharma & Healthcare
Report Page: 92
Chart: 93

PDF Download

Publication Date: 2025-08-19
Report Id: 2181863
Industry: Pharma & Healthcare
Report Page: 92
Chart: 93

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Omalizumab for Injection Definition
1.2 Global Omalizumab for Injection Market Size and Forecast
1.2.1 By Consumption Value, Global Omalizumab for Injection Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Omalizumab for Injection Market Size, 2020-2031
1.2.3 Global Omalizumab for Injection Average Selling Price (ASP), 2020-2031
1.3 China Omalizumab for Injection Market Size and Forecast
1.3.1 By Consumption Value, China Omalizumab for Injection Market Size, 2020-2031
1.3.2 By Sales Quantity, China Omalizumab for Injection Market Size, 2020-2031
1.3.3 China Omalizumab for Injection Average Selling Price (ASP), 2020-2031
1.4 Share of China Omalizumab for Injection Market with Respect to the Global Market
1.4.1 By Consumption Value, China Omalizumab for Injection Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Omalizumab for Injection Market Share in Global, 2020-2031
1.4.3 Omalizumab for Injection Market Size: China VS Global, 2020-2031
1.5 Omalizumab for Injection Market Dynamics
1.5.1 Omalizumab for Injection Market Drivers
1.5.2 Omalizumab for Injection Market Restraints
1.5.3 Omalizumab for Injection Industry Trends
1.5.4 Omalizumab for Injection Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Omalizumab for Injection, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Omalizumab for Injection, Global Market Share by Company, 2020-2025
2.3 Omalizumab for Injection Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Omalizumab for Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Omalizumab for Injection Concentration Ratio
2.6 Global Omalizumab for Injection Mergers & Acquisitions, Expansion Plans
2.7 Global Omalizumab for Injection Manufacturers Product Type
2.8 Head Office and Omalizumab for Injection Production Site of Key Manufacturer
2.9 Omalizumab for Injection Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Omalizumab for Injection, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Omalizumab for Injection, China Market Share by Company, 2020-2025
3.3 China Omalizumab for Injection Omalizumab for Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Omalizumab for Injection Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Omalizumab for Injection Capacity by Region
4.3 Global Omalizumab for Injection Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Omalizumab for Injection Production by Region, 2020-2031
4.5 Global Omalizumab for Injection Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Omalizumab for Injection Industry Chain
5.2 Omalizumab for Injection Upstream Analysis
5.2.1 Omalizumab for Injection Core Raw Materials
5.2.2 Main Manufacturers of Omalizumab for Injection Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Omalizumab for Injection Production Mode
5.6 Omalizumab for Injection Procurement Model
5.7 Omalizumab for Injection Industry Sales Model and Sales Channels
5.7.1 Omalizumab for Injection Sales Model
5.7.2 Omalizumab for Injection Typical Distributors

6 Sights by Type
6.1 Omalizumab for Injection Classification
6.1.1 Subcutaneous Powder For Injection
6.1.2 Subcutaneous Solution (150 mg/mL)
6.1.3 Subcutaneous Solution(75 mg/0.5 mL)
6.2 by Type, Global Omalizumab for Injection Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Omalizumab for Injection Consumption Value, 2020-2031
6.4 by Type, Global Omalizumab for Injection Sales Quantity, 2020-2031
6.5 by Type, Global Omalizumab for Injection Average Selling Price (ASP), 2020-2031

7 Sights by Application
7.1 Omalizumab for Injection Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 by Application, Global Omalizumab for Injection Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Omalizumab for Injection Consumption Value, 2020-2031
7.4 by Application, Global Omalizumab for Injection Sales Quantity, 2020-2031
7.5 by Application, Global Omalizumab for Injection Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Omalizumab for Injection Consumption Value, 2020 VS 2024 VS 2031
8.2 By Region, Global Omalizumab for Injection Consumption Value, 2020-2031
8.3 By Region, Global Omalizumab for Injection Sales Quantity, 2020-2031
8.4 North America
8.4.1 North America Omalizumab for Injection Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Omalizumab for Injection Market Size Market Share
8.5 Europe
8.5.1 Europe Omalizumab for Injection Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Omalizumab for Injection Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Omalizumab for Injection Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Omalizumab for Injection Market Size Market Share
8.7 South America
8.7.1 South America Omalizumab for Injection Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Omalizumab for Injection Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Omalizumab for Injection Market Size & CAGR, 2020 VS 2024 VS 2031
9.2 By Country, Global Omalizumab for Injection Consumption Value, 2020-2031
9.3 By Country, Global Omalizumab for Injection Sales Quantity, 2020-2031
9.4 United States
9.4.1 United States Omalizumab for Injection Market Size, 2020-2031
9.4.2 by Type, United States Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.4.3 by Application, United States Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Omalizumab for Injection Market Size, 2020-2031
9.5.2 by Type, Europe Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.5.3 by Application, Europe Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.6 China
9.6.1 China Omalizumab for Injection Market Size, 2020-2031
9.6.2 by Type, China Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.6.3 by Application, China Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Omalizumab for Injection Market Size, 2020-2031
9.7.2 by Type, Japan Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.7.3 by Application, Japan Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Omalizumab for Injection Market Size, 2020-2031
9.8.2 by Type, South Korea Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.8.3 by Application, South Korea Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Omalizumab for Injection Market Size, 2020-2031
9.9.2 by Type, Southeast Asia Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.9.3 by Application, Southeast Asia Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.10 India
9.10.1 India Omalizumab for Injection Market Size, 2020-2031
9.10.2 by Type, India Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.10.3 by Application, India Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Omalizumab for Injection Market Size, 2020-2031
9.11.2 by Type, Middle East & Africa Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031
9.11.3 by Application, Middle East & Africa Omalizumab for Injection Sales Quantity Market Share, 2024 VS 2031

10 Manufacturers Profile
10.1 Roche
10.1.1 Roche Company Information, Head Office, Market Area, and Industry Position
10.1.2 Roche Omalizumab for Injection Models, Specifications, and Application
10.1.3 Roche Omalizumab for Injection Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Roche Company Profile and Main Business
10.1.5 Roche Recent Developments
10.2 Novartis
10.2.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.2.2 Novartis Omalizumab for Injection Models, Specifications, and Application
10.2.3 Novartis Omalizumab for Injection Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Novartis Company Profile and Main Business
10.2.5 Novartis Recent Developments
10.3 CSPC Pharmaceutical Group
10.3.1 CSPC Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position
10.3.2 CSPC Pharmaceutical Group Omalizumab for Injection Models, Specifications, and Application
10.3.3 CSPC Pharmaceutical Group Omalizumab for Injection Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.3.4 CSPC Pharmaceutical Group Company Profile and Main Business
10.3.5 CSPC Pharmaceutical Group Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Omalizumab for Injection should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of %for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Omalizumab for Injection is a monoclonal antibody used primarily for the treatment of moderate to severe allergic asthma and chronic spontaneous urticaria. It works by specifically binding to immunoglobulin E (IgE), preventing IgE from interacting with its receptor, thereby inhibiting allergic and inflammatory responses. The medication is typically administered via subcutaneous injection and can improve symptoms and reduce acute exacerbations in long-term clinical management. In 2024, the global sales volume of Omalizumab for Injection reached approximately 26.39 million units, with an average price of 165 USD per unit.

Market Overview
The Omalizumab Injection market has maintained steady growth in recent years, driven by increasing demand for effective biologics among patients with allergic asthma and chronic spontaneous urticaria. Expansion of clinical guideline recommendations and long-term treatment protocols has improved market coverage, while the drug’s benefits in symptom management and prevention of acute exacerbations have contributed to overall market growth.

Regional Market Landscape
Globally, the United States accounts for 50% of the market, Europe 30%, Asia 15%, and other regions 5%, reflecting a market structure centered on North America with Europe following closely, while the Asian market is gradually expanding and emerging as a new growth area.

Key Manufacturers and Industry Competition
Roche and Novartis hold dominant positions as the primary developers and manufacturers worldwide, but competition is gradually intensifying with the emergence of biosimilars and other monoclonal antibodies. Companies maintain competitive advantages through scale expansion, global distribution networks, and clinical collaboration strategies, while enhancing product accessibility and patient coverage.

Technological Trends and Innovation Directions
Technological innovations focus on antibody structure optimization, development of long-acting formulations, and convenient delivery system design, which improve stability and patient adherence while supporting new indication expansion and combination therapy strategies. R&D progress is accelerating clinical application and market penetration.

Policy and Industry Development Drivers
Market development is driven by healthcare policy support, allergic disease prevention strategies, and optimized regulatory approvals for biologics. Clinical guideline recommendations and patient demand for innovative therapies further promote market expansion, while policy and public health factors jointly support long-term growth potential.

Future Outlook
Looking ahead, the Omalizumab Injection market is expected to maintain steady growth amid increasing global demand for allergic disease treatments, with potential increases in market concentration. Expansion into new indications, development of long-acting formulations, and regional market penetration will serve as key growth drivers. Technological innovation, policy support, and clinical adoption will collectively shape the long-term development landscape.

This report studies and analyses global Omalizumab for Injection status and future trends, helps the client to determine the Omalizumab for Injection market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Omalizumab for Injection, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Omalizumab for Injection market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Omalizumab for Injection sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Omalizumab for Injection sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Omalizumab for Injection key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Omalizumab for Injection key producing regions, capacity, production, and year over year growth
(6) Omalizumab for Injection industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Roche
Novartis
CSPC Pharmaceutical Group

Market segment by Type, covers
Subcutaneous Powder For Injection
Subcutaneous Solution (150 mg/mL)
Subcutaneous Solution(75 mg/0.5 mL)

Market segment by Application, can be divided into
Hospital
Clinic

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Omalizumab for Injection product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Omalizumab for Injection market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Omalizumab for Injection market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Omalizumab for Injection, percent & CAGR, 2020-2031
Chapter 5: Omalizumab for Injection industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions